MDIC In the News: Andy Fish on Driving Positive Change in the Medtech Ecosystem

In this Citeline article, MDIC President and CEO Andy Fish discusses the organization’s ongoing commitment to advancing patient engagement, cybersecurity, and medtech innovation. Highlighting MDIC’s role as a public-private partnership, Fish emphasizes the importance of collaboration with stakeholders like the FDA, industry leaders, and patient advocacy groups to drive meaningful change in the medical device ecosystem. From developing the first patient-centered benefit-risk framework to supporting early feasibility studies in the U.S., MDIC continues to provide tools and resources that enhance the development and approval of new medical technologies. Fish also outlines current priorities, including the National Evaluation System for health Technology (NEST) and support for companies participating in the FDA’s Total Product Lifecycle Advisory Program.

Learn more about MDIC’s impact on the medtech landscape,